Tulex Pharmaceuticals, a specialty pharmaceutical company located in Cranbury, NJ, has recently completed its new, multi-million-dollar, cGMP development and manufacturing facility capable of handling solvent processing and Wurster coating for commercial scale oral solid and liquid dosage forms.
 
Tulex has two proprietary technologies that focus on bio-availability enhancement and delivering predesigned drug release profiles that can be tailored to meet specific customer requirements.
 
Tulex out-licenses its technologies, as well as collaborates with customers in various stages of development for ANDA and NDA products. Tulex also serves as a CMO for commercial products or clinical supplies.